Beta-blockers for atherosclerosis prevention: a missed opportunity?

M Vrablik, A Corsini, E Tůmová - Current Atherosclerosis Reports, 2022 - Springer
Abstract Purpose of Review Current guidelines for the management of arterial hypertension
endorse β-adrenergic receptor blocking agents (beta-blockers, BBs) as being particularly …
被引用次数：12 相关文章

[引用][C] Beta-blockers for Atherosclerosis Prevention: a Missed Opportunity?

M Vrablik, A Corsini, E Tůmová - Current Atherosclerosis Reports, 2022 - cir.nii.ac.jp
Beta-blockers for Atherosclerosis Prevention: a Missed Opportunity? | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …

Beta-blockers for Atherosclerosis Prevention: a Missed Opportunity?

M Vrablik, A Corsini, E Tůmová - Current Atherosclerosis Reports, 2022 - europepmc.org
Current guidelines for the management of arterial hypertension endorse β-adrenergic
receptor blocking agents (beta-blockers, BBs) as being particularly useful for hypertension in …

Beta-blockers for Atherosclerosis Prevention: a Missed Opportunity?

M Vrablik, A Corsini, E Tůmová - Current atherosclerosis …, 2022 - pubmed.ncbi.nlm.nih.gov
Purpose of review Current guidelines for the management of arterial hypertension endorse β-
adrenergic receptor blocking agents (beta-blockers, BBs) as being particularly useful for …

Beta-blockers for Atherosclerosis Prevention: a Missed Opportunity?

M Vrablik, A Corsini, E Tůmová - CURRENT ATHEROSCLEROSIS …, 2022 - air.unimi.it
Purpose of review: Current guidelines for the management of arterial hypertension endorse
β-adrenergic receptor blocking agents (beta-blockers, BBs) as being particularly useful for …